Surrogate Endpoint Evaluation: Principal Stratification Criteria and the Prentice Definition
Author
Abstract
Suggested Citation
DOI: 10.1515/jci-2014-0007
Download full text from publisher
References listed on IDEAS
- Gilbert Peter B. & Hudgens Michael G. & Wolfson Julian, 2011. "Commentary on "Principal Stratification -- a Goal or a Tool?" by Judea Pearl," The International Journal of Biostatistics, De Gruyter, vol. 7(1), pages 1-15, September.
- Constantine E. Frangakis & Donald B. Rubin, 2002. "Principal Stratification in Causal Inference," Biometrics, The International Biometric Society, vol. 58(1), pages 21-29, March.
- Hua Chen & Zhi Geng & Jinzhu Jia, 2007. "Criteria for surrogate end points," Journal of the Royal Statistical Society Series B, Royal Statistical Society, vol. 69(5), pages 919-932, November.
- Peter B. Gilbert & Michael G. Hudgens, 2008. "Evaluating Candidate Principal Surrogate Endpoints," Biometrics, The International Biometric Society, vol. 64(4), pages 1146-1154, December.
- Dustin M. Long & Michael G. Hudgens, 2013. "Sharpening Bounds on Principal Effects with Covariates," Biometrics, The International Biometric Society, vol. 69(4), pages 812-819, December.
- Marshall M. Joffe & Tom Greene, 2009. "Related Causal Frameworks for Surrogate Outcomes," Biometrics, The International Biometric Society, vol. 65(2), pages 530-538, June.
- Jeremy M. G. Taylor & Yue Wang & Rodolphe Thiébaut, 2005. "Counterfactual Links to the Proportion of Treatment Effect Explained by a Surrogate Marker," Biometrics, The International Biometric Society, vol. 61(4), pages 1102-1111, December.
- Tyler J. VanderWeele, 2013. "Surrogate Measures and Consistent Surrogates," Biometrics, The International Biometric Society, vol. 69(3), pages 561-565, September.
- Dean Follmann, 2006. "Augmented Designs to Assess Immune Response in Vaccine Trials," Biometrics, The International Biometric Society, vol. 62(4), pages 1161-1169, December.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Zhichao Jiang & Peng Ding & Zhi Geng, 2016. "Principal causal effect identification and surrogate end point evaluation by multiple trials," Journal of the Royal Statistical Society Series B, Royal Statistical Society, vol. 78(4), pages 829-848, September.
- Ying Huang & Shibasish Dasgupta, 2019. "Likelihood-Based Methods for Assessing Principal Surrogate Endpoints in Vaccine Trials," Statistics in Biosciences, Springer;International Chinese Statistical Association, vol. 11(3), pages 504-523, December.
- Tyler J. VanderWeele, 2013. "Surrogate Measures and Consistent Surrogates," Biometrics, The International Biometric Society, vol. 69(3), pages 561-565, September.
- Gilbert Peter B. & Blette Bryan S. & Hudgens Michael G. & Shepherd Bryan E., 2020. "Post-randomization Biomarker Effect Modification Analysis in an HIV Vaccine Clinical Trial," Journal of Causal Inference, De Gruyter, vol. 8(1), pages 54-69, January.
- Layla Parast & Tianxi Cai & Lu Tian, 2023. "Testing for heterogeneity in the utility of a surrogate marker," Biometrics, The International Biometric Society, vol. 79(2), pages 799-810, June.
- Fatema Shafie Khorassani & Jeremy M. G. Taylor & Niko Kaciroti & Michael R. Elliott, 2023. "Incorporating Covariates into Measures of Surrogate Paradox Risk," Stats, MDPI, vol. 6(1), pages 1-23, February.
- Emily K. Roberts & Michael R. Elliott & Jeremy M. G. Taylor, 2023. "Solutions for surrogacy validation with longitudinal outcomes for a gene therapy," Biometrics, The International Biometric Society, vol. 79(3), pages 1840-1852, September.
- Corwin M. Zigler & Thomas R. Belin, 2012. "A Bayesian Approach to Improved Estimation of Causal Effect Predictiveness for a Principal Surrogate Endpoint," Biometrics, The International Biometric Society, vol. 68(3), pages 922-932, September.
- Ying Huang & Peter B. Gilbert & Julian Wolfson, 2013. "Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials," Biometrics, The International Biometric Society, vol. 69(2), pages 301-309, June.
- Denis Agniel & Layla Parast, 2021. "Evaluation of longitudinal surrogate markers," Biometrics, The International Biometric Society, vol. 77(2), pages 477-489, June.
- Gilbert Peter B. & Hudgens Michael G. & Wolfson Julian, 2011. "Commentary on "Principal Stratification -- a Goal or a Tool?" by Judea Pearl," The International Journal of Biostatistics, De Gruyter, vol. 7(1), pages 1-15, September.
- Guido Imbens & Nathan Kallus & Xiaojie Mao & Yuhao Wang, 2022. "Long-term Causal Inference Under Persistent Confounding via Data Combination," Papers 2202.07234, arXiv.org, revised Aug 2024.
- Julian Wolfson & Peter Gilbert, 2010. "Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials," Biometrics, The International Biometric Society, vol. 66(4), pages 1153-1161, December.
- Gilbert Peter B. & Blette Bryan S. & Shepherd Bryan E. & Hudgens Michael G., 2020. "Post-randomization Biomarker Effect Modification Analysis in an HIV Vaccine Clinical Trial," Journal of Causal Inference, De Gruyter, vol. 8(1), pages 54-69, January.
- Ying Huang, 2018. "Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling," Biometrics, The International Biometric Society, vol. 74(1), pages 27-39, March.
- Rui Zhuang & Ying Qing Chen, 2020. "Measuring Surrogacy in Clinical Research," Statistics in Biosciences, Springer;International Chinese Statistical Association, vol. 12(3), pages 295-323, December.
- Marshall M. Joffe, 2013. "Discussion on “Surrogate Measures and Consistent Surrogates”," Biometrics, The International Biometric Society, vol. 69(3), pages 569-573, September.
- Ying Huang & Peter B. Gilbert, 2011. "Comparing Biomarkers as Principal Surrogate Endpoints," Biometrics, The International Biometric Society, vol. 67(4), pages 1442-1451, December.
- Ghosh, Debashis, 2012. "A causal framework for surrogate endpoints with semi-competing risks data," Statistics & Probability Letters, Elsevier, vol. 82(11), pages 1898-1902.
- VanderWeele Tyler J, 2011. "Principal Stratification -- Uses and Limitations," The International Journal of Biostatistics, De Gruyter, vol. 7(1), pages 1-14, July.
More about this item
Keywords
clinical trial; principal stratification; surrogate paradox; vaccine efficacy trial; Zoster;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bpj:causin:v:3:y:2015:i:2:p:157-175:n:2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Peter Golla (email available below). General contact details of provider: https://www.degruyter.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.